NTZ significantly inhibited tumor growth, which resulted in decreased tumor weight and volume in the NTZ group (Fig. 6c, d) In addition, elevated levels of ING1, LC3 and SQSTM1 were observed in the NTZ group compared with the control group (Fig. 6e). The gene discussed is MAP1LC3A; the disease is neoplasm.